Dose escalation not an improvement for early-stage unfavorable Hodgkins

hodgkins-histopathology.jpg

Results from the German Hodgkin Study Group HD11 trial have been published in the Journal of Clinical Oncology and were not what researchers were expecting …

Read more about the results of this trial at CancerTreatment.net.

LymphomaInfo Social